Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB25FZS20
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,039
Award facts
- Contract value 100% obligated
- $26,038.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $26,038.50 by the Defense Logistics Agency on June 6, 2025, for the supply of Mirena 52 mg systems. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. The performance location is Park Ridge, Illinois, with an ultimate completion date of June 30, 2025.
As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the Defense Logistics Agency to deliver prescription medications and medical supplies directly to Department of Defense healthcare sites. The Mirena contraceptive device is among the company's extensive portfolio of pharmaceutical offerings, which includes branded and generic prescription drugs, biologics, over-the-counter medications, and specialty pharmaceuticals across multiple delivery formats. This award reflects the company's continued success in competing for federal pharmaceutical procurement requirements without set-aside restrictions, demonstrating its competitive strength in the open market despite its small business status.
Quick answers
Who was awarded contract SPE2DB25FZS20?
SPE2DB25FZS20 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 6, 2025.
How much is contract SPE2DB25FZS20 worth?
The government has obligated $26,039 on SPE2DB25FZS20.
Is contract SPE2DB25FZS20 an order under another contract?
Yes. SPE2DB25FZS20 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS20 competed?
The extent of competition for SPE2DB25FZS20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award